A Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate Efficacy and Safety of VQW-765 in Patients with Performance Anxiety
Brief description of study
Performance anxiety is a type of anxiety disorder characterized by excessive fear, discomfort, and self-consciousness in a variety of social situations related to performing in front of others such as public speaking. The purpose of the study is to evaluate the effect of an investigational drug called VQW-765 on symptoms associated with performance anxiety and to assess the safety of VQW-765.
Clinical Study Identifier: s20-01876
ClinicalTrials.gov Identifier: NCT04800237
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
